Terminus' growth supports development of smart city

Chinese e-commerce and artificial intelligence companies are doubling down on the future to connect every device.  Internet of Things IoT startup Terminus Technologies has completed the first round of its Series C fundraising at total Rmb 2 billion $283 million. China Everbright Limited led the round and remains a controlling shareholder. Continue Reading

Chinese biomedical CRO seals $77m fundraising for R&D push

Beijing Biocytogen, a contract research organisation which specialises in gene-modified animal models, said it has raised Rmb543 million $77 million from a group of government-owned and private investors in its Series D round of funding. Leading the latest funding round are China Life Healthcare Fund and SDIC Venture Capital, the investment arm Continue Reading

BestSign signs on the dotted line to dominate China’s electronic signature market

Hangzhou-based electronic signature service provider BestSign acquired rival 51signing on Wednesday. This is the company’s second acquisition in the Chinese electronic signature market. Prior to this, BestSign bought counterpart QuickSign in 2017. With the takeover of 51signing, it has extended its lead in the market. BestSign topped the Chinese electronic signature market Continue Reading

Alibaba invests in education platform amid tighter rules

Knowbox, a Beijing-based education platform, said on Thursday that it had closed a $150 million Series D fundraising deal, to develop artificial intelligence AI. Alibaba led the round of investment, joined by Jack Ma’s investment fund Yunfeng Capital, Bertelsmann Asia Investments, and C Ventures. The fundraising proceeds will mainly be used Continue Reading

Chinese animal gene modifier set to close $79m funding

Chinese gene-modified animal provider Biocytogen is going to close its Series D funding of $79 million on July 23, with four investors and a management team participating. In an exclusive interview with FinanceAsia, chairman Shen Yuelei spoke about plans for his biotech company and the timeline to expand its business from gene-modified animals, Continue Reading

Why SEAsian & Indian VC deals are outpacing China's

Venture capital investment has developed rapidly in Southeast Asia and India in the past four to five years. This growing ecosphere is also attracting more investors from within and outside the region. Even Chinese investors, who used to invest aggressively only in China, are actively visiting India and Southeast Asia Continue Reading

Nowhere to hide: Chinese startups struggle to attract both private & public investors

Unprofitable, fast-growing Chinese startups have, for the last five years, been able to tap private investors flush with cash, allowing them to put off filing for an initial public offering and the associated public scrutiny of their accounts that will no longer be the easy option. China’s fund-raising machine has Continue Reading

Chinese asset manager kick-starts IPO process

Beijing-based asset allocation platform Lixiangjia said on Thursday that it had completed its $45 million Series D funding. The company didn’t disclose the name of investors. Meanwhile, the startup has begun the auditing process for an overseas IPO, according to an unnamed source at a New York investment bank. Founded in 2013, Continue Reading